Skip to main content
. 2011 Jun 14;19(9):1737–1746. doi: 10.1038/mt.2011.113

Figure 2.

Figure 2

Cyclophosphamide (CP) administration did not influence the presence of the virus in circulation nor the neutralizing antibody response. Serum from patients treated with oncolytic adenovirus in combination with one of the three different regimens of CP was collected and analyzed for (a) presence of the virus, and (b) neutralizing antibodies for adenovirus. i.v., intravenous.